| Title : ApoC-III as Therapeutic Target: Is it Primetime for Clinical Use? - Biolo_2025_Curr.Atheroscler.Rep_27_72 |
| Author(s) : Biolo M , Galimberti F , Portinari C , Bertocco S , Tosin P , Casula M , Previato L , Zambon S , Simioni P , Zambon A |
| Ref : Curr Atheroscler Rep , 27 :72 , 2025 |
| Abstract : |
| PubMedSearch : Biolo_2025_Curr.Atheroscler.Rep_27_72 |
| PubMedID: 40679547 |
| Title : ApoC-III as Therapeutic Target: Is it Primetime for Clinical Use? - Biolo_2025_Curr.Atheroscler.Rep_27_72 |
| Author(s) : Biolo M , Galimberti F , Portinari C , Bertocco S , Tosin P , Casula M , Previato L , Zambon S , Simioni P , Zambon A |
| Ref : Curr Atheroscler Rep , 27 :72 , 2025 |
| Abstract : |
| PubMedSearch : Biolo_2025_Curr.Atheroscler.Rep_27_72 |
| PubMedID: 40679547 |
| Title : ApoC-III as Therapeutic Target: Is it Primetime for Clinical Use? - Biolo_2025_Curr.Atheroscler.Rep_27_72 |
| Author(s) : Biolo M , Galimberti F , Portinari C , Bertocco S , Tosin P , Casula M , Previato L , Zambon S , Simioni P , Zambon A |
| Ref : Curr Atheroscler Rep , 27 :72 , 2025 |
| Abstract : |
| PubMedSearch : Biolo_2025_Curr.Atheroscler.Rep_27_72 |
| PubMedID: 40679547 |